February 2017 issue
January 2017 issue
December 2015 Issue
Feature: How Shall We Live?
Indexes for Volume 6, 2011 through Volume 9, 2014
Index for Volume 10, 2015
November 2015 Issue
Feature: Medications that Must Be Available without a Prescription from a Pharmacist
New Drug Review: Brexpiprazole (Rexulti – Otsuka)
October 2015 Issue
Feature: The FTC should just say NO! to CVS acquiring Target pharmacies and to Walgreens acquiring Rite Aid!
New Drug Review: Sacubitril/valsartan (Entresto – Novartis)
September 2015 Issue
Feature: Daraprim – The Ultimate Drug Pricing Outrage?
New Drug Review: Suvorexant (Belsomra – Merck)
August 2015 Issue
Feature: CVS Recommendations about the Cholesterol Guidelines are Not Credible When Its Pharmacists Do Not Have Enough Staff and Time to Practice Optimally
New Therapeutic Agents Marketed in the United States in 2014
July 2015 Issue
Feature: Time Out!*
New Drug Review: Edoxaban tosylate monohydrate (Savaysa – Daiichi-Sankyo)
March 2015 Issue
Feature: PHARMACY'S VISION FOR 2015 [2004-2014 Rest in Peace]
New Drug Review: Vorapaxar sulfate (Zontivity – Merck)
February 2015 Issue
Feature: Drug Shortages and High-Priced Generics – Pharmacy Should Establish Our Own Generics Pharmaceutical Company!
New Drug Review: Olodaterol hydrochloride (Striverdi Respimat – Boehringer Ingelheim)
January 2015 Issue
Feature: Express Scripts Made the Wrong Formulary Decision that is a Disservice to its Customers
New Drug Review: Ledipasvir/sofosbuvir (Harvoni – Gilead Sciences)
New Drug Review: Ombitasvir, paritaprevir, ritonavir, dasabuvir sodium monohydrate (Viekira Pak – AbbVie)